Navigation Links
NanoLogix Inc. Announces Historical First in Energy Generation With Bioreactor-Produced Hydrogen at Welch's
Date:9/17/2007

HUBBARD, Ohio, Sept. 17 /PRNewswire-FirstCall/ -- NanoLogix, Inc. (OTC: NNLX), a nano-biotechnology company, announced it has achieved a historical event with the first onsite generation of electricity using hydrogen gas produced from its bioreactor prototype facility at Welch Foods Inc., a Cooperative in Pennsylvania.

A 5.5 kW generator converted to run on hydrogen was utilized for the demonstration. The generator ran flawlessly on hydrogen gas produced by NanoLogix's hydrogen bioreactor system and powered multiple strings of 100- watt light bulbs. "To the best of our knowledge, this is the first time in history that electricity has been generated anywhere onsite using hydrogen produced through the use of bacteria to digest waste", said Harry Diz, Department Chair and Professor of Environmental Engineering at Gannon University and NanoLogix Bioreactor Development chief. Video: http://www.youtube.com/watch?v=cS_jmMwy9D8

Paul Zorzie, Welch's Engineering Manager, stated, "Welch's is happy to provide the site at which this groundbreaking research into generating alternative energy from waste is taking place. We look forward to the potential of building upon these developments to scale up and use this energy for our operation."

Bret Barnhizer, Chairman and CEO of NanoLogix, stated, "We are delighted at the results of the work by Professor Diz and associates and anticipate potential upscaling of the Welch's operation to commercial bioreactor status. The Welch's development, enabling conversion of sugar from their wastewater stream to produce hydrogen, has contributed immeasurably to ongoing research and development for processing other types of waste streams. Linked to that development and following our business plan for expansion, in the spring of 2008 we intend to begin bioreactor construction at the Erie Wastewater Treatment Plant for the extraction of hydrogen from their p
'/>"/>

SOURCE NanoLogix Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., December 2 Pepscan Holding NV,the Netherlands b...icking,technology for the generation of immune the...m E.M. Mol, Ph.D. as new Chief Executive Officer. ...ans corporate functions and,the overall management... to,Pepscan more than 20 years of management exper...
(Date:12/2/2009)... Pte Ltd today announced data presentations on its...n Society of Hematology 51st Annual Meeting and Ex... on the clinical results from the Phase 1 dose-esc...rability and pharmacokinetic/pharmacodynamic (PK/P...mg. These doses were administered once daily conti...
(Date:12/2/2009)...e-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZ...eutical company focused on endocrine therapy and o...ug Administration (FDA) has granted Fast Track des...tor compound, perifosine (KRX-0401), for the treat...x Biopharmaceuticals, Inc. ("Keryx") ( KERX), is A...
(Date:12/2/2009)...ing to the National Institute of Health, 40 percen...es already have some stage of diabetic retinopathy...ed by leaky blood vessels, is a major cause of bli...ost feared diabetic complications. In fact, up to...r 10 years or more will experience some form of di...
Breaking Biology Technology:Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4
...ility in identity theft cases was spelled out duri...e Conference, and healthcare providers got a real ...sing a hypothetical case of identity theft from an... & Friedrich demonstrated how much trouble health...n they take steps to prevent security breaches tha...
...tion system for boats and recreational vehicles. T... software for use by hikers, campers and sportsmen...ilking system that is healthier for cows, which, i...ry out "Wisconsin" to you, welcome to the third an...even finalists from 14 Wisconsin communities are e...
...e the wrong way, but he believes friction sometime...szewski as the state,s CIO in 2003 to bring greate... enterprise, and he certainly expected some bumps ...ive snags that some large-scale IT projects have e...ng target now pegged at $9 million annually - will...
Other Biology Technology:Managing the nightmare of identity theft 2Managing the nightmare of identity theft 3Managing the nightmare of identity theft 4Business plan contest finalists reflect state's economic character 2Business plan contest finalists reflect state's economic character 3Embattled state CIO stands his ground 2Embattled state CIO stands his ground 3
(Date:12/3/2009)...estment in energy efficient technologies research,...uncil (EPSRC) Chief Executive Dave Delpy believes ...esearch has already brought us fuel cells, marine,...nt is needed to develop the capabilities of differ...n targets by 2020 and limit the impact of climate ...
(Date:12/2/2009)... have a more difficult time quitting smoking than ...ut acculturation has no affect on Latinas odds of ...blished in Cancer Epidemiology, Biomarkers & Prev... Cancer Research. The December issue has a special...ng cessation differently for Latino men and women,...
(Date:12/2/2009)... exposed to cigarette smoking scenes in movies are...this may be part of the acculturation process asso...tudy findings. , "Our study supports an R-rating ...e global implementation of the World Health Organi...ich includes guidelines for countries to restrict ...
Breaking Biology News(10 mins):Research is vital to a cleaner, greener, low carbon future 2Acculturation affects smoking cessation success among Latinos 2Watching movies featuring characters who smoke negatively influences Mexican-American teens 2American Chemical Society Awards John R Engen for Scientific Achievements 55858 1American Chemical Society Awards John R Engen for Scientific Achievements 55858 2American Chemical Society Awards John R Engen for Scientific Achievements 55858 3New Medical Technology Company CareFusion Spins Off From Cardinal Health Begins Trading on NYSE 55856 1New Medical Technology Company CareFusion Spins Off From Cardinal Health Begins Trading on NYSE 55856 2Cardinal Health Completes Spinoff of CareFusion Corp 55853 1Cardinal Health Completes Spinoff of CareFusion Corp 55853 2Cardinal Health Completes Spinoff of CareFusion Corp 55853 3
...s being told their children have peanut allergies ...t peanuts safely, a study by researchers at the Un...dren,s Hospital has found. , Peanut allergies occu...sian Society of Clinical Immunology and Allergy. ...Brynn Wainstein, a Sydney Children,s Hospital immu...
...and least studied freshwater turtles has been foun...he threatened species can be saved from extinction...), World Wildlife Fund (WWF), the Cambodian Fisher...rvation Team captured and released an 11-kilogram...le (Pelochelys cantorii) during a survey in March....
...Great Lakes and neighboring waterways is approachi... Cornell professor of aquatic animal medicine in t...rhagic septicemia virus (VHSV), which causes anemi...d in 19 species and poses a potential threat to Ne...t’s pretty obvious this is an epidemic even if it ...
Other Biology News:Peanut allergies overstated, study finds 2Rare soft-shell turtle, nesting ground found in Cambodia 2Rare soft-shell turtle, nesting ground found in Cambodia 3Cornell lab confirms deadly fish virus spreading to new species 2
Corning Roller Bottle Easy Grip Caps, Sterile from Sigma-Aldrich
Affymetrix Standard Data Analysis Report from Asuragen, Inc.
CORNING ROLLER BOTTLE, 850CM2, PS, EASY GRIP CAP, GRADUATED from Sigma-Aldrich
DKW/Juglans Basal Salt Mixture from Sigma-Aldrich
Biology Products: